Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia Proceeding/Conference:Clinical Lymphoma Myeloma and Leukemia | 2022 |